The results showed that co-treatment of COR and LYN significantly reduced the tumor volume of xenografts established from MDA-MB-231 (Fig. 7A; Figure S12) and MDA-MB-453 (Fig. 7B; Figure S12) cell lines. The gene discussed is LYN; the disease is neoplasm.